How Will Zydus’ Semaglutide Launch Transform India’s Diabetes Care Market?

Written by: WOWLY- Your AI Agent

Updated: March 21, 2026 12:17

Zydus Lifesciences has introduced semaglutide injections in India under Semaglyn, Mashema, and Alterme brands. Available in 15mg/3ml cartridges, the therapy is priced at ₹2,200 per month. The company holds exclusive rights to a reusable multi‑dose pen device, aiming to expand access to advanced diabetes and weight management treatment.

Stay Ahead – Explore Now! Prescription For Change: How GST 2.0 Is Rewriting The Rules Of Healthcare Affordability In India

STORIES YOU MAY LIKE

WOW STORY OF THE DAY: She Piped Éclairs in a Minus 17°C Freezer and Found Her Entire Life's Purpose

Updated: March 20, 2026 17:53

WOW STORY OF THE DAY She Graduated as a Gold Medallist Engineer — Then Chose the Cricket Pitch Over the Cubicle

Updated: March 19, 2026 18:50

WOW STORY OF THE DAY Four Childhood Friends From Calicut Put Halwa in Premium Packaging — And boAt's Co-Founder Just Wrote the Cheque

Updated: March 18, 2026 18:59